At a time when the healthcare industry is increasingly dependent on-marine derived bio-active compounds for various diseases, the Central Marine Fisheries Research Institute (CMFRI) is poised launch a natural product from the sea against thyroid disorder. The CMFRI has already developed nutraceutical products for diabetes, arthritis and cholesterol from marine organisms such as seaweeds and green mussel.
Dr. A. Gopalakrishnan, Director CMFRI said that the marine nutraceutical product developed by the Institute for thyroid dysfunction is undergoing final clinical trials and that the product will be commercialised after interaction with the healthcare industry soon.
Director CMFRI added that High value bioactive metabolites from marine organisms were attracting attention because of the growing demand for new compounds of ‘marine natural’ origin, having potential applications in pharmaceutical fields. The functional foods, enriched with natural ingredients have been proven to provide beneficial action for human health.
Source: Aquaculture Spectrum